Crossmark

Glucokinase activators contribute to gastrointestinal disease risks through metabolic-immune interplay in the gut-liver axis: insights from a multi-omics study

Crossref DOI link: https://doi.org/10.1007/s00592-025-02571-7

Published Online: 2025-08-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Yunlan https://orcid.org/0000-0001-8957-1245
Zhou, Bingqian

Ke, Xing https://orcid.org/0009-0001-0093-0641
Ma, Yanhui https://orcid.org/0000-0002-6681-9751
Funding

Funding for this research was provided by:

Shanghai Municipal Health Commission (202340054)
License Information

Text and Data Mining valid from 2025-08-01

Version of Record valid from 2025-08-01
More Information

Article History

Received: 17 April 2025

Accepted: 14 July 2025

First Online: 1 August 2025

Declarations

:

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Document is current

Any future updates will be listed below